z-logo
open-access-imgOpen Access
Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province
Author(s) -
Yousef Jalalabadi,
Alireza Shirazi,
Mohammad-Reza Ghavam–Nasiri,
Seyed Amir Aledavood,
Dariush Sardari,
Bahram Memar,
Soodabeh Shahidsales,
Fatemeh Varshoee-Tabrizi,
Parvane Dehghan,
Hassan Vosughiniya
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.199428
Subject(s) - medicine , immunohistochemistry , esophageal cancer , biopsy , cyclooxygenase , proportional hazards model , chemoradiotherapy , cancer , pathology , oncology , gastroenterology , enzyme , biochemistry , chemistry
Esophageal cancer is the third most common cancer in Iran. Neoadjuvant chemoradiotherapy (NCRT) is the appropriate treatment for esophageal cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here